Small molecules inhibitor WP1130 29 and Chinese medicine Formononetin 6 were reported to inhibit USP5, which further indicated that targeting USP5 might be an effective strategy in pancreatic cancer treatment. The gene discussed is USP5; the disease is familial pancreatic carcinoma.